Clinical trial
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00468208 |
|---|---|
| Title | Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis |
| Official title | A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Office of Rare Diseases (ORD) NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Rare Diseases Clinical Research Network |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | Abatacept |
| Enrollment | 20 |
| Start date | Feb 1, 2008 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | May 2, 2007 |
| Last update posted | Jan 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: